PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HQY vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between HQY and SPY is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

HQY vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in HealthEquity, Inc. (HQY) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

0.00%10.00%20.00%30.00%40.00%50.00%SeptemberOctoberNovemberDecember2025February
48.66%
10.44%
HQY
SPY

Key characteristics

Sharpe Ratio

HQY:

1.18

SPY:

1.88

Sortino Ratio

HQY:

1.72

SPY:

2.53

Omega Ratio

HQY:

1.23

SPY:

1.35

Calmar Ratio

HQY:

1.16

SPY:

2.83

Martin Ratio

HQY:

5.21

SPY:

11.74

Ulcer Index

HQY:

7.18%

SPY:

2.02%

Daily Std Dev

HQY:

31.68%

SPY:

12.64%

Max Drawdown

HQY:

-60.65%

SPY:

-55.19%

Current Drawdown

HQY:

-2.44%

SPY:

-0.42%

Returns By Period

In the year-to-date period, HQY achieves a 16.44% return, which is significantly higher than SPY's 4.15% return. Over the past 10 years, HQY has outperformed SPY with an annualized return of 18.97%, while SPY has yielded a comparatively lower 13.18% annualized return.


HQY

YTD

16.44%

1M

6.66%

6M

48.66%

1Y

39.53%

5Y*

4.97%

10Y*

18.97%

SPY

YTD

4.15%

1M

1.22%

6M

10.44%

1Y

24.34%

5Y*

14.62%

10Y*

13.18%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HQY vs. SPY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HQY
The Risk-Adjusted Performance Rank of HQY is 7979
Overall Rank
The Sharpe Ratio Rank of HQY is 8181
Sharpe Ratio Rank
The Sortino Ratio Rank of HQY is 7575
Sortino Ratio Rank
The Omega Ratio Rank of HQY is 7474
Omega Ratio Rank
The Calmar Ratio Rank of HQY is 8181
Calmar Ratio Rank
The Martin Ratio Rank of HQY is 8181
Martin Ratio Rank

SPY
The Risk-Adjusted Performance Rank of SPY is 7878
Overall Rank
The Sharpe Ratio Rank of SPY is 7878
Sharpe Ratio Rank
The Sortino Ratio Rank of SPY is 7575
Sortino Ratio Rank
The Omega Ratio Rank of SPY is 7878
Omega Ratio Rank
The Calmar Ratio Rank of SPY is 7979
Calmar Ratio Rank
The Martin Ratio Rank of SPY is 8282
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HQY vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for HealthEquity, Inc. (HQY) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for HQY, currently valued at 1.18, compared to the broader market-2.000.002.001.181.88
The chart of Sortino ratio for HQY, currently valued at 1.72, compared to the broader market-4.00-2.000.002.004.006.001.722.53
The chart of Omega ratio for HQY, currently valued at 1.23, compared to the broader market0.501.001.502.001.231.35
The chart of Calmar ratio for HQY, currently valued at 1.16, compared to the broader market0.002.004.006.001.162.83
The chart of Martin ratio for HQY, currently valued at 5.21, compared to the broader market-10.000.0010.0020.0030.005.2111.74
HQY
SPY

The current HQY Sharpe Ratio is 1.18, which is lower than the SPY Sharpe Ratio of 1.88. The chart below compares the historical Sharpe Ratios of HQY and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
1.18
1.88
HQY
SPY

Dividends

HQY vs. SPY - Dividend Comparison

HQY has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.16%.


TTM20242023202220212020201920182017201620152014
HQY
HealthEquity, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
SPDR S&P 500 ETF
1.16%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%

Drawdowns

HQY vs. SPY - Drawdown Comparison

The maximum HQY drawdown since its inception was -60.65%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for HQY and SPY. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-2.44%
-0.42%
HQY
SPY

Volatility

HQY vs. SPY - Volatility Comparison

HealthEquity, Inc. (HQY) has a higher volatility of 6.06% compared to SPDR S&P 500 ETF (SPY) at 2.93%. This indicates that HQY's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%SeptemberOctoberNovemberDecember2025February
6.06%
2.93%
HQY
SPY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab